Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases

被引：3
作者：
Manfredi, Mariangela [1 ]
Van Hoovels, Lieve [2 ,3 ]
Benucci, Maurizio [4 ]
De Luca, Riccardo [5 ]
Coccia, Carmela [5 ]
Bernardini, Pamela [5 ]
Russo, Edda [5 ]
Amedei, Amedeo [5 ]
Guiducci, Serena [5 ]
Grossi, Valentina [1 ]
Bossuyt, Xavier [2 ,6 ]
Perricone, Carlo [7 ]
Infantino, Maria [1 ]
机构：
[1] S Giovanni Dio Hosp, Immunol & Allergol Lab Unit, I-50143 Florence, Italy
[2] Univ Leuven, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium
[3] Onze Lieve Vrouw Hosp, Dept Lab Med, B-9300 Aalst, Belgium
[4] S Giovanni Dio Hosp, Rheumatol Unit, I-50143 Florence, Italy
[5] Univ Florence, Dept Clin & Expt Med, I-50139 Florence, Italy
[6] Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium
[7] Univ Perugia, Dept Med & Surg, Rheumatol Unit, I-06122 Perugia, Italy
来源：
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 04期
关键词：
suPAR; rheumatoid arthritis; autoimmune diseases; rheumatic diseases; C-REACTIVE PROTEIN; FECAL CALPROTECTIN; HEALTHY DONORS; SERUM-LEVELS; PLASMA; INFLAMMATION; LUPUS; ASSOCIATION; ARTHRITIS; CANCER;
D O I：
10.3390/jpm13040688
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
The soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential prognostic biomarker in several inflammatory diseases. Indeed, in many diseases, including cancer, diabetes, cardiovascular diseases, kidney diseases, and inflammatory disorders, higher suPAR concentrations have been associated with disease severity, disease relapse, and mortality. Our review describes and discusses the supporting literature concerning the promising role of suPAR as a biomarker in different autoimmune rheumatic and non-rheumatic diseases.
引用
收藏
页数：12
相关论文
共 58 条
  • [1] uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
    Angel Pavon, Miguel
    Arroyo-Solera, Irene
    Virtudes Cespedes, Maria
    Casanova, Isolda
    Leon, Xavier
    Mangues, Ramon
    [J]. ONCOTARGET, 2016, 7 (35) : 57351 - 57366
  • [2] The urokinase receptor
    Behrendt, N
    Stephens, RW
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (04): : 191 - 204
  • [3] Ankylosing spondylitis
    Braun, Juergen
    Sieper, Joachim
    [J]. LANCET, 2007, 369 (9570) : 1379 - 1390
  • [4] Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity
    Burcsar, Szilard
    Toldi, Gergely
    Kovacs, Laszlo
    Szalay, Balazs
    Vasarhelyi, Barna
    Balog, Attila
    [J]. BIOMARKERS, 2021, 26 (05) : 443 - 449
  • [5] Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis
    Butt, Sheraz
    Jeppesen, Jorgen L.
    Iversen, Line Vinderslev
    Fenger, Mogens
    Eugen-Olsen, Jesper
    Andersson, Charlotte
    Jacobsen, Soren
    [J]. PLOS ONE, 2021, 16 (02):
  • [6] Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
    Canani, R. Berni
    Terrin, G.
    Rapacciuolo, L.
    Miele, E.
    Siani, M. C.
    Puzone, C.
    Cosenza, L.
    Staiano, A.
    Troncone, R.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 (07) : 547 - 553
  • [7] Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface
    Cerinic, MM
    Generini', S
    Partsch, G
    Pignone, A
    Dini, G
    Konttinen, YT
    Del Rosso, M
    [J]. LIFE SCIENCES, 1998, 63 (06) : 441 - 453
  • [8] Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480
  • [9] Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints
    Choi, Hyun M.
    Lee, Yeon-Ah
    Yang, Hyung-In
    Yoo, Mung C.
    Kim, Kyoung S.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2011, 14 (04) : 320 - 324
  • [10] THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION
    DANO, K
    BEHRENDT, N
    BRUNNER, N
    ELLIS, V
    PLOUG, M
    PYKE, C
    [J]. FIBRINOLYSIS, 1994, 8 : 189 - 203
123456